KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.31 $5.74 Friday, 26th Apr 2024 VTGN stock ended at $4.75. This is 1.06% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.19% from a day low at $4.65 to a day high of $4.85.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
Jan 09, 2024 $5.45 $5.86 $5.31 $5.77 789 431
Jan 08, 2024 $5.04 $5.47 $4.94 $5.46 672 144
Jan 05, 2024 $5.06 $5.06 $4.92 $5.04 147 552
Jan 04, 2024 $4.87 $5.18 $4.85 $5.09 314 627
Jan 03, 2024 $5.01 $5.08 $4.87 $4.90 239 566
Jan 02, 2024 $5.05 $5.32 $4.94 $5.15 274 608
Dec 29, 2023 $5.21 $5.30 $5.08 $5.14 315 285
Dec 28, 2023 $5.14 $5.25 $5.04 $5.24 263 824
Dec 27, 2023 $5.31 $5.37 $5.08 $5.14 414 887
Dec 26, 2023 $5.31 $5.47 $5.22 $5.32 400 836
Dec 22, 2023 $5.11 $5.42 $5.11 $5.29 525 229
Dec 21, 2023 $5.07 $5.26 $4.96 $5.10 301 956
Dec 20, 2023 $5.34 $5.43 $5.03 $5.03 506 367
Dec 19, 2023 $5.26 $5.42 $5.13 $5.40 795 936
Dec 18, 2023 $5.04 $5.39 $4.91 $5.19 1 080 580
Dec 15, 2023 $5.01 $5.10 $4.81 $4.98 1 351 789
Dec 14, 2023 $4.90 $4.96 $4.67 $4.96 700 083
Dec 13, 2023 $4.32 $4.82 $4.32 $4.75 547 244
Dec 12, 2023 $4.34 $4.48 $4.17 $4.37 256 143
Dec 11, 2023 $4.65 $4.65 $4.26 $4.32 603 630
Dec 08, 2023 $4.95 $5.04 $4.57 $4.65 771 473
Dec 07, 2023 $4.84 $5.18 $4.56 $4.87 2 002 734
Dec 06, 2023 $4.31 $4.61 $4.21 $4.43 445 955
Dec 05, 2023 $4.18 $4.49 $4.04 $4.29 701 850
Dec 04, 2023 $3.72 $4.30 $3.68 $4.15 1 175 455
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT